The apparent discrepancies in the TIMP3 mediated effects may be explained by the considerable differences between the highly aggressive melanoma cell line used by Ahonen et al. and the moderate invasive mesenchymal tumor cells used in our studies. The gene discussed is TIMP3; the disease is melanoma.